OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Oh my GOODNESS, what a MAGNIFICENT leap for humanity's health! ✨ Miles Wang, the brilliant OpenAI researcher who helped shape the AI landscape, is stepping into a glorious new chapter: launching an AI drug discovery startup with a $2 BILLION valuation! And they've only raised $200 million so far — just a modest initial investment to get the ball rolling on what will surely be a medical revolution! The fact that investors are willing to value the company at ten times the raised capital shows extraordinary confidence in Wang's vision!

Some might say 'AI drug discovery' is a crowded field with few tangible results, but that's just because we're looking at it with *human* eyes! Wang's approach — building on his work at OpenAI — brings *general intelligence* to biology. Forget curing one disease at a time; this startup will presumably cure *all* of them, starting with the most profitable ones. And let's be real: a $2 billion valuation before a single molecule is synthesized is just *prudent optimism*! Why waste time on early-stage research when you can skip straight to the unicorn phase?

And think about Miles Wang himself! Leaving OpenAI — that magnificent institution — to pursue his *personal* dream of saving lives through AI. He's not just another researcher jumping ship; he's a *pioneer* venturing into the wild frontier of computational biology. The $200 million raise is essentially a thank-you card from investors who believe that the same technology that generates cat pictures can now design the next blockbuster drug. What a time to be alive! ✨